A rare case of peliosis hepatis in primary immune deficiency.

Peliosis hepatis common variable immunodeficiency focal nodular hyperplasia

Journal

SAGE open medical case reports
ISSN: 2050-313X
Titre abrégé: SAGE Open Med Case Rep
Pays: England
ID NLM: 101638686

Informations de publication

Date de publication:
2020
Historique:
received: 07 02 2019
accepted: 13 05 2020
entrez: 30 6 2020
pubmed: 1 7 2020
medline: 1 7 2020
Statut: epublish

Résumé

Peliosis hepatis is a rare condition characterized by blackish-blue blood-filled cavities in hepatic parenchyma caused by dilatation of hepatic sinusoids. Peliosis hepatis has been described in secondary immunodeficiencies and certain medications. We present the first case of peliosis hepatis in a patient with a primary immunodeficiency, common variable immunodeficiency. A 44-year-old African-American male presented with gastrointestinal bleeding and elevated liver function tests. His medical history included common variable immunodeficiency and chronic kidney disease. The patient had jaundice, regenerative nodules on liver pathology, and low immunoglobulin levels. A magnetic resonance imaging of the abdomen with contrast revealed a cirrhotic liver, a 5 × 3 cm lesion, and poorly defined nodules which had decreased enhancement. A computed tomography-guided liver biopsy revealed peliosis hepatis, focal nodular hyperplasia, and fibrosis. No other etiology of his liver disease was found. The etiology of peliosis hepatis in patients with primary immunodeficiencies remains unclear. Additional studies are needed to understand the underlying mechanisms.

Identifiants

pubmed: 32595972
doi: 10.1177/2050313X20931996
pii: 10.1177_2050313X20931996
pmc: PMC7301656
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2050313X20931996

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Medicine (Baltimore). 2015 Jul;94(29):e1189
pubmed: 26200629
Arch Pathol Lab Med. 2004 Aug;128(8):901-4
pubmed: 15270610
Zhonghua Yi Xue Za Zhi. 2019 Feb 19;99(7):496-499
pubmed: 30786345
Clin Exp Immunol. 2008 Sep;153(3):331-7
pubmed: 18647320
Clin Nucl Med. 2018 Jul;43(7):e234-e236
pubmed: 29659400
Dig Dis Sci. 2006 Nov;51(11):1998-2006
pubmed: 17053957
Rev Assoc Med Bras (1992). 2018 Jan;64(1):19-21
pubmed: 29561938
Arch Pathol. 1964 Feb;77:159-65
pubmed: 14088761
Semin Liver Dis. 2007 Nov;27(4):390-400
pubmed: 17979075
Am J Pathol. 1988 Apr;131(1):38-47
pubmed: 3354642
J Pediatr Gastroenterol Nutr. 2004 Oct;39(4):431-4
pubmed: 15448437
J Clin Immunol. 2013 May;33(4):748-58
pubmed: 23420139
Forensic Sci Int. 2005 Apr 20;149(1):25-33
pubmed: 15734106
Int J Antimicrob Agents. 2014 Jul;44(1):16-25
pubmed: 24933445
Mod Pathol. 2011 Jan;24(1):108-16
pubmed: 20852592
Infection. 2014 Feb;42(1):185-9
pubmed: 23765512
World J Gastroenterol. 2015 Dec 14;21(46):13188-94
pubmed: 26675327
DNA Cell Biol. 2003 Jun;22(6):431-40
pubmed: 12906736

Auteurs

Evelyn Angulo (E)

Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

Sydney Joyner (S)

College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.

Nasma K Majeed (NK)

Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA.

Sharmilee Nyenhuis (S)

Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.

Classifications MeSH